Faculty Collaboration Database

Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg 2011 Apr;141(4):932-9

Date

07/08/2010

Pubmed ID

20605026

DOI

10.1016/j.jtcvs.2010.03.046

Scopus ID

2-s2.0-79952985548 (requires institutional sign-in at Scopus site)   197 Citations

Abstract

OBJECTIVE: The Levitronix CentriMag (Levitronix LLC, Waltham, Mass) ventricular assist system is designed for temporary left, right, or biventricular support. Advantages include ease of use, excellent reliability, and low thrombosis risk,. which may allow wider application of short-term support and improved outcomes in patients with cardiogenic shock. This multi-institutional study evaluated safety, effectiveness, and outcomes of the CentriMag in patients with cardiogenic shock.

METHODS: Thirty-eight patients were supported at 7 centers. Patients included 12 after cardiotomy, 14 after myocardial infarction, and 12 with right ventricular failure after implantable left ventricular assist device placement. Devices were implanted in left (n = 8), right (n = 12), or biventricular (n = 18) configuration. Support was continued until recovery, transplantation, or implantation of long-term ventricular assist device.

RESULTS: Mean support duration for the entire cohort (n = 38) was 13 days (1-60 days), with 47% of patients (18/38) surviving 30 days after device removal. Mean CentriMag biventricular support (n = 18) duration was 15 days (1-60 days), with 44% (8/18) surviving at 30 days. Mean CentriMag right ventricular support with a commercially available left ventricular assist device (n = 12) duration was 14 days (1-29 days), with 58% (7/12) surviving at 30 days. Complications included bleeding (21%), infection (5%), respiratory failure (3%), hemolysis (5%), and neurologic dysfunction (11%). There were no CentriMag or pump failures.

CONCLUSIONS: In this preliminary study, the CentriMag provided short-term support for patients with cardiogenic shock with a low incidence of device-related complications and no device failures.

Author List

John R, Long JW, Massey HT, Griffith BP, Sun BC, Tector AJ, Frazier OH, Joyce LD

MESH terms used to index this publication - Major topics in bold

Adult
Aged
Female
Heart-Assist Devices
Hemodynamics
Hemolysis
Humans
Male
Middle Aged
Pilot Projects
Prosthesis Design
Recovery of Function
Shock, Cardiogenic
Thromboembolism
Time Factors
Treatment Outcome
United States
Ventricular Function, Left
Ventricular Function, Right